DOP2011000346A - Composiciones adyuvantes que comprende un agente de isotonicidad no-ionico - Google Patents

Composiciones adyuvantes que comprende un agente de isotonicidad no-ionico

Info

Publication number
DOP2011000346A
DOP2011000346A DO2011000346A DO2011000346A DOP2011000346A DO P2011000346 A DOP2011000346 A DO P2011000346A DO 2011000346 A DO2011000346 A DO 2011000346A DO 2011000346 A DO2011000346 A DO 2011000346A DO P2011000346 A DOP2011000346 A DO P2011000346A
Authority
DO
Dominican Republic
Prior art keywords
adjutive
isotonicity agent
compositions included
ionic isotonicity
ionic
Prior art date
Application number
DO2011000346A
Other languages
English (en)
Inventor
Dominique Ingrid Lemoine
Veronique Henderickx
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40937237&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2011000346(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of DOP2011000346A publication Critical patent/DOP2011000346A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DO2011000346A 2009-06-10 2011-11-11 Composiciones adyuvantes que comprende un agente de isotonicidad no-ionico DOP2011000346A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0910046.2A GB0910046D0 (en) 2009-06-10 2009-06-10 Novel compositions

Publications (1)

Publication Number Publication Date
DOP2011000346A true DOP2011000346A (es) 2012-01-15

Family

ID=40937237

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2011000346A DOP2011000346A (es) 2009-06-10 2011-11-11 Composiciones adyuvantes que comprende un agente de isotonicidad no-ionico

Country Status (31)

Country Link
US (2) US20120087976A1 (es)
EP (1) EP2440242B1 (es)
JP (3) JP5647677B2 (es)
KR (1) KR101473686B1 (es)
CN (2) CN102458457B (es)
AU (1) AU2010257538B2 (es)
BR (1) BRPI1012890B1 (es)
CA (1) CA2764421C (es)
CL (1) CL2011003113A1 (es)
CO (1) CO6440528A2 (es)
CY (1) CY1115522T1 (es)
DK (1) DK2440242T3 (es)
DO (1) DOP2011000346A (es)
EA (1) EA024074B1 (es)
ES (1) ES2494442T3 (es)
GB (1) GB0910046D0 (es)
HR (1) HRP20140792T1 (es)
IL (1) IL216231A0 (es)
MA (1) MA33412B1 (es)
MX (1) MX2011013162A (es)
MY (1) MY159819A (es)
NZ (1) NZ596503A (es)
PE (1) PE20120319A1 (es)
PL (1) PL2440242T3 (es)
PT (1) PT2440242E (es)
RS (1) RS53550B1 (es)
SG (1) SG176638A1 (es)
SI (1) SI2440242T1 (es)
SM (1) SMT201400134B (es)
UA (1) UA104888C2 (es)
WO (1) WO2010142685A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG175707A1 (en) 2009-06-10 2011-12-29 Chugai Pharmaceutical Co Ltd Tetracyclic compound
NZ608312A (en) 2010-08-20 2015-02-27 Chugai Pharmaceutical Co Ltd Composition containing tetracyclic compound
CN106822882A (zh) * 2010-12-14 2017-06-13 葛兰素史密丝克莱恩生物有限公司 分枝杆菌抗原组合物
WO2014050781A1 (ja) 2012-09-25 2014-04-03 中外製薬株式会社 Ｒｅｔ阻害剤
JP6608422B2 (ja) * 2014-03-25 2019-11-20 ザ ガバメント オブ ザ ユナイテッド ステイツ，アズ リプリゼンティッド バイ ザ セクレタリー オブ ジ アーミー モノホスホリルリピッドａ（ｍｐｌａ）含有リポソーム組成物およびサポニンを含む非毒性アジュバント製剤
MX2016013735A (es) 2014-04-25 2017-03-09 Chugai Pharmaceutical Co Ltd Cristales novedosos de compuesto tetraciclico.
US10350214B2 (en) 2014-04-25 2019-07-16 Chugai Seiyaku Kabushiki Kaisha Preparation containing tetracyclic compound at high dose
TWI803187B (zh) 2014-08-08 2023-05-21 日商中外製藥股份有限公司 包含４環性化合物的非晶質體之固體分散體及製劑
BR112017013982A2 (pt) 2015-01-16 2018-01-02 Chugai Seiyaku Kabushiki Kaisha fármaco de combinação
MX2019006728A (es) * 2016-12-07 2019-12-02 Glaxosmithkline Biologicals Sa Nuevo proceso.
KR20200098476A (ko) * 2017-10-16 2020-08-20 아쥬반스 테크놀로지스 인코포레이티드 트리테르펜 사포닌 유사체
BR112020010635A2 (pt) 2017-12-01 2020-11-10 Glaxosmithkline Biologicals S.A. extração de saponina
BR112020010790A2 (pt) * 2017-12-01 2020-11-10 Glaxosmithkline Biologicals S.A. purificação da saponina
KR102635225B1 (ko) 2018-09-04 2024-02-07 추가이 세이야쿠 가부시키가이샤 4환성 화합물의 제조방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804381A (en) 1996-10-03 1998-09-08 Cornell Research Foundation Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
HU219056B (hu) * 1993-03-23 2001-02-28 Smithkline Beecham Biologicals Sa 3-O-Dezacilezett monofoszforil-lipid A-t tartalmazó vakcinakészítmény
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
DE19803453A1 (de) * 1998-01-30 1999-08-12 Boehringer Ingelheim Int Vakzine
DK1659178T3 (da) 1998-02-05 2010-07-12 Glaxosmithkline Biolog Sa Fremgangsmåde til oprensning eller fremstilling af et MAGE-protein
WO1999056776A2 (en) * 1998-05-07 1999-11-11 Corixa Corporation Adjuvant composition and methods for its use
JP3765232B2 (ja) 2000-11-16 2006-04-12 株式会社ジェイテクト 電動式パワーステアリング装置及びこれに用いる歯車の製造方法
GB0409940D0 (en) 2004-05-04 2004-06-09 Glaxosmithkline Biolog Sa Vaccine
GB0411411D0 (en) * 2004-05-21 2004-06-23 Glaxosmithkline Biolog Sa Vaccines
WO2006056142A1 (fr) * 2004-11-29 2006-06-01 Changchun Huapu Biotechnology Co., Ltd. Desoxynucleotides cpg a brin unique a utiliser comme adjuvant
KR101408113B1 (ko) * 2005-06-27 2014-06-16 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신 제조 방법
TWI457133B (zh) * 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
TW200902049A (en) 2007-01-15 2009-01-16 Glaxosmithkline Biolog Sa Fusion protein
AU2008207025B2 (en) 2007-01-15 2012-08-23 Glaxosmithkline Biologicals Sa Vaccine
CL2008001491A1 (es) * 2007-05-24 2008-11-28 Glaxosmithkline Biolog Sa Composicion liofilizada que comprende uno o mas antigenos y un agonista del receptor de tipo toll 9 (tlr9); y procedimiento de preparacion.
GB0910045D0 (en) * 2009-06-10 2009-07-22 Glaxosmithkline Biolog Sa Novel compositions

Also Published As

Publication number Publication date
JP2012529464A (ja) 2012-11-22
MX2011013162A (es) 2012-01-30
JP2015042646A (ja) 2015-03-05
NZ596503A (en) 2013-08-30
EP2440242A1 (en) 2012-04-18
RS53550B1 (en) 2015-02-27
JP5647677B2 (ja) 2015-01-07
SG176638A1 (en) 2012-01-30
DK2440242T3 (da) 2014-09-01
CN102458457A (zh) 2012-05-16
EA201190286A1 (ru) 2012-06-29
GB0910046D0 (en) 2009-07-22
CO6440528A2 (es) 2012-05-15
KR101473686B1 (ko) 2014-12-18
CL2011003113A1 (es) 2012-08-31
AU2010257538A1 (en) 2011-12-08
PT2440242E (pt) 2014-08-29
WO2010142685A1 (en) 2010-12-16
ES2494442T3 (es) 2014-09-15
JP2016193912A (ja) 2016-11-17
MA33412B1 (fr) 2012-07-03
UA104888C2 (uk) 2014-03-25
BRPI1012890A2 (pt) 2018-02-27
CA2764421C (en) 2016-12-06
IL216231A0 (en) 2012-01-31
US20180021417A1 (en) 2018-01-25
SI2440242T1 (sl) 2014-09-30
SMT201400134B (it) 2014-11-10
US20120087976A1 (en) 2012-04-12
JP5977789B2 (ja) 2016-08-24
PE20120319A1 (es) 2012-04-16
PL2440242T3 (pl) 2014-11-28
CA2764421A1 (en) 2010-12-16
BRPI1012890B1 (pt) 2022-03-22
HRP20140792T1 (hr) 2014-10-10
AU2010257538B2 (en) 2016-10-20
CN104367997A (zh) 2015-02-25
EA024074B1 (ru) 2016-08-31
CN102458457B (zh) 2015-05-20
EP2440242B1 (en) 2014-06-25
JP6261647B2 (ja) 2018-01-17
CY1115522T1 (el) 2017-01-04
KR20120031497A (ko) 2012-04-03
MY159819A (en) 2017-02-15
CN104367997B (zh) 2019-01-22

Similar Documents

Publication Publication Date Title
DOP2011000346A (es) Composiciones adyuvantes que comprende un agente de isotonicidad no-ionico
SMT201500053B (it) 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori
BRPI1011836A2 (pt) imunonanoterapêuticos que fornecem uma resposta induzida por th1
BR112012010676A2 (pt) partícula de alta eficiência que compreende um agente de benefício.
DK2634231T3 (da) Sammensætninger
BRPI0908265A2 (pt) Composição de limpeza que proporciona vantagens residuais
BR112012000652A2 (pt) composições contendo partículas de liberação de agente de benefício
DOP2011000363A (es) Composiciones pesticidas que incluyen coadyuvantes polimericos
DK2396339T3 (da) Pesticidsammensætninger
BRPI1014543A2 (pt) composições pesticidas
BR112013016210A2 (pt) composições fluidas compreendendo um agente estruturador.
BR112012001798A2 (pt) composição de limpeza que proporciona benefícios residuais
DOP2011000396A (es) Composiciones novedosas
BR112012005247A2 (pt) agente antifitoviral
BR112012003977A2 (pt) composições que induzem ajuda de célula t
BRPI0909488A2 (pt) brocha
BR112012007952A2 (pt) composição detergente
BR112012005039A2 (pt) Composição detergente
ES2465478T8 (es) Composiciones farmacéuticas que comprenden brivaracetam
BRPI1010690A2 (pt) composições
DK2396338T3 (da) Pesticidsammensætninger
BRPI0907235A2 (pt) Composição de revestimento de metal
BRPI0910106A2 (pt) composições curáveis
BR112013024082A2 (pt) composições de agente branqueador fluorescente
CL2013001019A1 (es) Composicion de detergente en particulas que comprende un agente de fluorescencia sulfonatado.